We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Assay Determines Suitability of Nanoparticles for In Vivo Use

By LabMedica International staff writers
Posted on 28 Feb 2017
Print article
Image: Macrophages with ingested nanoparticles (green) (Photo courtesy of the Bourquin Laboratory, University of Geneva).
Image: Macrophages with ingested nanoparticles (green) (Photo courtesy of the Bourquin Laboratory, University of Geneva).
A team of Swiss researchers has developed a flow cytometry-based test to determine whether specific types of nanoparticles are suitable for use in humans or animals.

Nanoparticles as carriers of drugs, genetic material, or other substances of biomedical interest are under investigation in many laboratories. However, their interaction with immune cells has been difficult to predict. Macrophages are among the first type of cells that take up nanoparticles, mediating inflammation and thus immunological responses. A recent study described a highly reproducible screening method to study the interaction of nanoparticles with macrophages.

Investigators at the University of Geneva and the University of Fribourg reported in the February 2, 2017, online edition of the journal Nanoscale that they had developed a flow cytometry-based assay that could determine for a single nanoparticle sample whether the nanoparticles were taken up by macrophages, whether the nanoparticles caused death of the macrophages, and whether the nanoparticles triggered an inflammatory immune response.

To perform the assay, macrophages were brought into contact with the nanoparticles for 24 hours, and were then evaluated in a flow cytometer. The fluorescence emitted by the macrophages made it possible to count them and characterize their activation levels. Since the particles themselves were fluorescent, the investigators could also measure the amount of particles ingested by the macrophages. Thus, the three elements could be determined simultaneously in two or three days on a very small amount of particles.

"Researchers can spend years developing a nanoparticle, without knowing what impact it will have on a living organism," said senior author Dr. Carole Bourquin, professor of medicine at the University of Geneva. "So there was a real need to design an effective screening method that could be implemented at the beginning of the development process. Indeed, if the nanoparticles aren’t compatible, several years of research were simply thrown away."

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.